New User? Sign Up | Sign In

Insider Trading - Entasis Therapeutics Holdings Inc. (ETTX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
ETTX Insider Trading Transactions for Entasis Therapeutics Holdings Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-01-09
Sale
2020-01-13
10:47 am
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
Topper James N
FHM LIFE SCIENCES VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
10% Owner
50,000 $5 $250,010 1,299,953
(Direct)
View
2018-09-28
Purchase
2018-10-02
9:42 pm
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
375,887 $15 $5,638,305 1,349,953
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:41 pm
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
337,724 $15 $5,065,860 1,180,178
(Direct)
View
2018-09-28
Purchase
2018-10-02
9:40 pm
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
337,724 $15 $5,065,860 1,180,178
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:39 pm
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
337,724 $15 $5,065,860 1,180,178
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:38 pm
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
453,395 $15 $6,800,925 1,623,405
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:38 pm
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
375,887 $15 $5,638,305 1,349,953
(Direct)
View
2018-09-28
Purchase
2018-10-02
9:36 pm
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
453,395 $15 $6,800,925 1,623,405
(Indirect)
View
2018-09-28
Purchase
2018-10-02
9:35 pm
Entasis Therapeutics Holdings Inc. ETTX ASTRAZENECA PLC
ASTRAZENECA AB
10% Owner
246,666 $15 $3,699,990 2,164,855
(Indirect)
View
2018-09-28
Purchase
2018-10-02
4:46 pm
Entasis Therapeutics Holdings Inc. ETTX TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
Former 10% Owner
262,539 $15 $3,938,085 1,020,748
(Indirect)
View
2018-09-28
Purchase
2018-10-01
4:36 pm
Entasis Therapeutics Holdings Inc. ETTX Novo Holdings A/S
10% Owner
1,089,835 $15 $16,347,525 2,181,843
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-01-23
Option Award
2020-01-27
4:07 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Altarac David
Chief Medical Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:06 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Perros Manoussos
CEO
145,000 $4.94 145,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:06 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Kimble Eric Wilson
Chief Commercial Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:05 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Keiley Elizabeth M
General Counsel
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:05 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Gutch Michael
CFO
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:04 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
50,000 $4.94 50,000
(Direct)
View
2020-01-23
Option Award
2020-01-27
4:04 pm
N/A
2030-01-22
Entasis Therapeutics Holdings Inc. ETTX Mueller John Patrick
Chief Development Officer
50,000 $4.94 50,000
(Direct)
View
2019-11-04
Option Award
2019-11-06
4:03 pm
N/A
2029-11-03
Entasis Therapeutics Holdings Inc. ETTX Altarac David
Chief Medical Officer
120,000 $5.7 120,000
(Direct)
View
2019-08-05
Option Award
2019-08-06
4:10 pm
N/A
2029-08-04
Entasis Therapeutics Holdings Inc. ETTX Mayer Howard
Director
15,000 $6.44 15,000
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Meek David D.
Director
7,500 $6.12 15,000
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Meek David D.
Director
15,000 $6.12 15,000
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:04 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX HASTINGS DAVID C
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Norden Gregory
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Behanna Heather
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:03 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
7,500 $6.12 7,500
(Direct)
View
2019-06-19
Option Award
2019-06-21
4:02 pm
N/A
2029-06-18
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
7,500 $6.12 7,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:04 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:03 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:02 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Perros Manoussos
CEO
123,500 $5.66 123,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:02 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Norden Gregory
Director
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:01 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Mueller John Patrick
Chief Development Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
5:00 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Isaacs Robin
Chief Medical Officer
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:58 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX HASTINGS DAVID C
Director
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:57 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Gutch Michael
CFO
56,500 $5.66 56,500
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:57 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
15,000 $5.66 15,000
(Direct)
View
2019-01-18
Option Award
2019-01-22
4:56 pm
N/A
2029-01-17
Entasis Therapeutics Holdings Inc. ETTX Behanna Heather
Director
15,000 $5.66 15,000
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
11,788 $3.74 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
10,236 $3.11 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
2026-10-21
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
11,788 $3.74 24,858
(Direct)
View
2018-12-21
Exercise
2018-12-26
4:45 pm
N/A
2027-11-21
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
10,236 $3.11 24,858
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
337,707 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
251,487 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
320,898 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
7,000,000 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
5,212,833 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:42 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Topper James N
Director
10% Owner
6,651,574 $0 1,349,953
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
359,267 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
458,425 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
7,446,904 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:41 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Sofinnova Venture Partners IX L.P.
Sofinnova Management IX L.L.C.
HEALY JAMES
Mehra Anand
POWELL MICHAEL
10% Owner
9,502,249 $0 1,180,178
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
359,267 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
458,425 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
7,446,904 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:40 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Preston Heather
Director
10% Owner
9,502,249 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
359,267 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
458,425 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
7,446,904 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:39 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Pivotal bioVenture Partners Fund I L.P.
Pivotal bioVenture Partners Fund I G.P. L.P.
Pivotal bioVenture Partners Fund I U.G.P. Ltd
10% Owner
9,502,249 $0 1,180,178
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
361,829 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
323,341 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
412,583 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
7,500,000 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
6,702,213 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX GALAKATOS NICHOLAS
Director
10% Owner
8,552,024 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
337,707 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
251,487 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
320,898 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
7,000,000 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
5,212,833 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:38 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Frazier Life Sciences VIII L.P.
FHM LIFE SCIENCES VIII L.L.C.
Heron Patrick J
FHM LIFE SCIENCES VIII L.P.
10% Owner
6,651,574 $0 1,349,953
(Direct)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
361,829 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
323,341 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
412,583 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
7,500,000 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
6,702,213 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Clarus Ventures III LLC
Simon Nicholas
LIPTAK ROBERT
HENNER DENNIS
Requadt Scott
WHEELER KURT
10% Owner
8,552,024 $0 1,623,405
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:35 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX ASTRAZENECA PLC
ASTRAZENECA AB
10% Owner
1,918,185 $0 2,164,855
(Indirect)
View
2018-09-28
Conversion
2018-10-02
9:35 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX ASTRAZENECA PLC
ASTRAZENECA AB
10% Owner
33,499,900 $0 2,164,855
(Indirect)
View
2018-09-28
Conversion
2018-10-02
4:46 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
Former 10% Owner
735,924 $0 1,020,748
(Indirect)
View
2018-09-28
Other
2018-10-02
4:46 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
Former 10% Owner
22,285 $0 1,020,748
(Indirect)
View
2018-09-28
Conversion
2018-10-02
4:46 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX TPG Group Holdings (SBS) Advisors Inc.
BONDERMAN DAVID
COULTER JAMES G
Former 10% Owner
15,254,237 $0 1,020,748
(Indirect)
View
2018-09-28
Conversion
2018-10-01
4:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Novo Holdings A/S
10% Owner
1,092,008 $0 2,181,843
(Direct)
View
2018-09-28
Conversion
2018-10-01
4:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Novo Holdings A/S
10% Owner
7,000,000 $0 2,181,843
(Direct)
View
2018-09-28
Conversion
2018-10-01
4:36 pm
N/A
N/A
Entasis Therapeutics Holdings Inc. ETTX Novo Holdings A/S
10% Owner
14,237,288 $0 2,181,843
(Direct)
View
2018-09-25
Option Award
2018-09-27
6:14 pm
N/A
2028-09-24
Entasis Therapeutics Holdings Inc. ETTX Perros Manoussos
CEO
79,698 $15 79,698
(Direct)
View
2018-09-25
Option Award
2018-09-27
6:07 pm
N/A
2028-09-24
Entasis Therapeutics Holdings Inc. ETTX Tommasi Ruben
Chief Scientific Officer
50,411 $15 50,411
(Direct)
View
2018-09-25
Option Award
2018-09-27
6:01 pm
N/A
2028-09-24
Entasis Therapeutics Holdings Inc. ETTX Mueller John Patrick
Chief Development Officer
7,265 $15 7,265
(Direct)
View
Goto page 0, 1, Next